表紙
市場調查報告書

經皮藥物輸送的全球市場

Transdermal Drug Delivery

出版商 Global Industry Analysts, Inc. 商品編碼 909364
出版日期 內容資訊 英文 97 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
經皮藥物輸送的全球市場 Transdermal Drug Delivery
出版日期: 2019年10月01日內容資訊: 英文 97 Pages
簡介

本報告提供全球經皮藥物輸送市場概要,彙整趨勢·發展的影響因素分析,競爭企業與市場佔有率,世界及各地區·各主要國家的市場規模的變化與預測,主要企業的簡介等系統性資訊。

第1章 調查手法

第2章 摘要整理

  • 市場概要
    • 全球市場的競爭企業的市場佔有率
    • 全球市場的競爭企業的市場佔有率:方案
  • 主要企業
  • 市場趨勢與發展因素
  • 全球市場預測
    • 全球市場的估計·預測:各區各國
    • 市場方案:各區各國
    • 全球主要地區的市場佔有率的轉變
    • 各最終用途
      • 心血管
      • CNS
      • 皮膚科
      • 其他
      • 疼痛管理

第3章 市場分析

  • 各地區市場分析
  • 美國
  • 加拿大
  • 日本
  • 中國
  • 歐洲
  • 法國
  • 德國
  • 義大利
  • 英國
  • 其他歐洲
  • 亞太地區
  • 其他地區 (RoW)

第4章 競爭企業

  • ADVANSOR A/S
  • BITZER KUHLMASCHINENBAU GMBH
  • BALTIMORE AIRCOIL COMPANY
  • CARNOT REFRIGERATION
  • CARRIER COMMERCIAL REFRIGERATION EUROPE
  • CLARIANT AG
  • DANFOSS GMBH
  • DOWDUPONT
  • EMERSON CLIMATE TECHNOLOGIES
  • GREEN & COOL
  • HALLIBURTON
  • HENRY TECHNOLOGIES
  • KEMIRA OYJ
  • LMP SYSTEMS INC.
  • MAYEKAWA MFG.
  • NALCO AN ECLOAB COMPANY
  • PARKER HANNIFIN CORPORATION
  • SCM FRIGO S.P.A
  • SCHLUMBERGER
  • SHECCO SPRL
  • STEPAN COMPANY
  • THE LUBRIZOL CORPORATION

第5章 調查資料

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: MCP15288

Transdermal Drug Delivery market worldwide is projected to grow by US$2.8 Billion, driven by a compounded growth of 7.2%. Cardiovascular, one of the segments analyzed and sized in this study, displays the potential to grow at over 7.3%. The shifting dynamics supporting this growth makes it critical for businesses in this space to keep abreast of the changing pulse of the market. Poised to reach over US$2.1 Billion by the year 2025, Cardiovascular will bring in healthy gains adding significant momentum to global growth.

Representing the developed world, the United States will maintain a 8.2% growth momentum. Within Europe, which continues to remain an important element in the world economy, Germany will add over US$130.8 Million to the region's size and clout in the next 5 to 6 years. Over US$132.9 Million worth of projected demand in the region will come from Rest of Europe markets. In Japan, Cardiovascular will reach a market size of US$206.2 Million by the close of the analysis period. As the world's second largest economy and the new game changer in global markets, China exhibits the potential to grow at 6.9% over the next couple of years and add approximately US$489.9 Million in terms of addressable opportunity for the picking by aspiring businesses and their astute leaders. Presented in visually rich graphics are these and many more need-to-know quantitative data important in ensuring quality of strategy decisions, be it entry into new markets or allocation of resources within a portfolio. Several macroeconomic factors and internal market forces will shape growth and development of demand patterns in emerging countries in Asia-Pacific. All research viewpoints presented are based on validated engagements from influencers in the market, whose opinions supersede all other research methodologies.

Competitors identified in this market include, among others, Antares Pharma, Inc.; Bayer AG; Durect Corporation; Iontera, Inc.; Janssen Pharmaceuticals, Inc.; Nitto Denko Corporation; Novartis AG; Pantec Biosolutions AG; Tesa Labtec GmbH; Teva Pharmaceutical Industries Ltd.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

  • Global Competitor Market Shares
  • Transcritical CO2 Systems Competitor Market Share Scenario Worldwide (in %): 2019 & 2025

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE

  • TABLE 1: Transdermal Drug Delivery Global Market Estimates and Forecasts in US$ Million by Region/Country: 2018-2025
  • TABLE 2: Transdermal Drug Delivery Global Retrospective Market Scenario in US$ Million by Region/Country: 2009-2017
  • TABLE 3: Transdermal Drug Delivery Market Share Shift across Key Geographies Worldwide: 2009 VS 2019 VS 2025
  • TABLE 4: Cardiovascular (End-Use) Global Opportunity Assessment in US$ Million by Region/Country: 2018-2025
  • TABLE 5: Cardiovascular (End-Use) Historic Sales Analysis in US$ Million by Region/Country: 2009-2017
  • TABLE 6: Cardiovascular (End-Use) Percentage Share Breakdown of Global Sales by Region/Country: 2009 VS 2019 VS 2025
  • TABLE 7: CNS (End-Use) Worldwide Sales in US$ Million by Region/Country: 2018-2025
  • TABLE 8: CNS (End-Use) Historic Demand Patterns in US$ Million by Region/Country: 2009-2017
  • TABLE 9: CNS (End-Use) Market Share Shift across Key Geographies: 2009 VS 2019 VS 2025
  • TABLE 10: Dermatology (End-Use) Demand Potential Worldwide in US$ Million by Region/Country: 2018-2025
  • TABLE 11: Dermatology (End-Use) Historic Sales Analysis in US$ Million by Region/Country: 2009-2017
  • TABLE 12: Dermatology (End-Use) Share Breakdown Review by Region/Country: 2009 VS 2019 VS 2025
  • TABLE 13: Other End-Uses (End-Use) Worldwide Latent Demand Forecasts in US$ Million by Region/Country: 2018-2025
  • TABLE 14: Other End-Uses (End-Use) Global Historic Analysis in US$ Million by Region/Country: 2009-2017
  • TABLE 15: Other End-Uses (End-Use) Distribution of Global Sales by Region/Country: 2009 VS 2019 VS 2025
  • TABLE 16: Pain Management (End-Use) Global Market Estimates & Forecasts in US$ Million by Region/Country: 2018-2025
  • TABLE 17: Pain Management (End-Use) Retrospective Demand Analysis in US$ Million by Region/Country: 2009-2017
  • TABLE 18: Pain Management (End-Use) Market Share Breakdown by Region/Country: 2009 VS 2019 VS 2025

III. MARKET ANALYSIS

  • GEOGRAPHIC MARKET ANALYSIS
  • UNITED STATES
    • Market Facts & Figures
    • US Transcritical CO2 Systems Market Share (in %) by Company: 2019 & 2025
    • TABLE 19: United States Transdermal Drug Delivery Latent Demand Forecasts in US$ Million by End-Use: 2018 to 2025
    • TABLE 20: Transdermal Drug Delivery Historic Demand Patterns in the United States by End-Use in US$ Million for 2009-2017
    • TABLE 21: Transdermal Drug Delivery Market Share Breakdown in the United States by End-Use: 2009 VS 2019 VS 2025
  • CANADA
    • TABLE 22: Canadian Transdermal Drug Delivery Market Quantitative Demand Analysis in US$ Million by End-Use: 2018 to 2025
    • TABLE 23: Transdermal Drug Delivery Market in Canada: Summarization of Historic Demand Patterns in US$ Million by End-Use for 2009-2017
    • TABLE 24: Canadian Transdermal Drug Delivery Market Share Analysis by End-Use: 2009 VS 2019 VS 2025
  • JAPAN
    • TABLE 25: Japanese Demand Estimates and Forecasts for Transdermal Drug Delivery in US$ Million by End-Use: 2018 to 2025
    • TABLE 26: Japanese Transdermal Drug Delivery Market in US$ Million by End-Use: 2009-2017
    • TABLE 27: Transdermal Drug Delivery Market Share Shift in Japan by End-Use: 2009 VS 2019 VS 2025
  • CHINA
    • TABLE 28: Chinese Demand for Transdermal Drug Delivery in US$ Million by End-Use: 2018 to 2025
    • TABLE 29: Transdermal Drug Delivery Market Review in China in US$ Million by End-Use: 2009-2017
    • TABLE 30: Chinese Transdermal Drug Delivery Market Share Breakdown by End-Use: 2009 VS 2019 VS 2025
  • EUROPE
    • Market Facts & Figures
    • European Transcritical CO2 Systems Market: Competitor Market Share Scenario (in %) for 2019 & 2025
    • TABLE 31: European Transdermal Drug Delivery Market Demand Scenario in US$ Million by Region/Country: 2018-2025
    • TABLE 32: Transdermal Drug Delivery Market in Europe: A Historic Market Perspective in US$ Million by Region/Country for the Period 2009-2017
    • TABLE 33: European Transdermal Drug Delivery Market Share Shift by Region/Country: 2009 VS 2019 VS 2025
    • TABLE 34: European Transdermal Drug Delivery Addressable Market Opportunity in US$ Million by End-Use: 2018-2025
    • TABLE 35: Transdermal Drug Delivery Market in Europe: Summarization of Historic Demand in US$ Million by End-Use for the Period 2009-2017
    • TABLE 36: European Transdermal Drug Delivery Market Share Analysis by End-Use: 2009 VS 2019 VS 2025
  • FRANCE
    • TABLE 37: Transdermal Drug Delivery Quantitative Demand Analysis in France in US$ Million by End-Use: 2018-2025
    • TABLE 38: French Transdermal Drug Delivery Historic Market Review in US$ Million by End-Use: 2009-2017
    • TABLE 39: French Transdermal Drug Delivery Market Share Analysis: A 17-Year Perspective by End-Use for 2009, 2019, and 2025
  • GERMANY
    • TABLE 40: Transdermal Drug Delivery Market in Germany: Annual Sales Estimates and Forecasts in US$ Million by End-Use for the Period 2018-2025
    • TABLE 41: German Transdermal Drug Delivery Market in Retrospect in US$ Million by End-Use: 2009-2017
    • TABLE 42: Transdermal Drug Delivery Market Share Distribution in Germany by End-Use: 2009 VS 2019 VS 2025
  • ITALY
    • TABLE 43: Italian Demand for Transdermal Drug Delivery in US$ Million by End-Use: 2018 to 2025
    • TABLE 44: Transdermal Drug Delivery Market Review in Italy in US$ Million by End-Use: 2009-2017
    • TABLE 45: Italian Transdermal Drug Delivery Market Share Breakdown by End-Use: 2009 VS 2019 VS 2025
  • UNITED KINGDOM
    • TABLE 46: United Kingdom Demand Estimates and Forecasts for Transdermal Drug Delivery in US$ Million by End-Use: 2018 to 2025
    • TABLE 47: United Kingdom Transdermal Drug Delivery Market in US$ Million by End-Use: 2009-2017
    • TABLE 48: Transdermal Drug Delivery Market Share Shift in the United Kingdom by End-Use: 2009 VS 2019 VS 2025
  • REST OF EUROPE
    • TABLE 49: Rest of Europe Transdermal Drug Delivery Addressable Market Opportunity in US$ Million by End-Use: 2018-2025
    • TABLE 50: Transdermal Drug Delivery Market in Rest of Europe: Summarization of Historic Demand in US$ Million by End-Use for the Period 2009-2017
    • TABLE 51: Rest of Europe Transdermal Drug Delivery Market Share Analysis by End-Use: 2009 VS 2019 VS 2025
  • ASIA-PACIFIC
    • TABLE 52: Transdermal Drug Delivery Quantitative Demand Analysis in Asia-Pacific in US$ Million by End-Use: 2018-2025
    • TABLE 53: Asia-Pacific Transdermal Drug Delivery Historic Market Review in US$ Million by End-Use: 2009-2017
    • TABLE 54: Asia-Pacific Transdermal Drug Delivery Market Share Analysis: A 17-Year Perspective by End-Use for 2009, 2019, and 2025
  • REST OF WORLD
    • TABLE 55: Rest of World Transdermal Drug Delivery Market Quantitative Demand Analysis in US$ Million by End-Use: 2018 to 2025
    • TABLE 56: Transdermal Drug Delivery Market in Rest of World: Summarization of Historic Demand Patterns in US$ Million by End-Use for 2009-2017
    • TABLE 57: Rest of World Transdermal Drug Delivery Market Share Analysis by End-Use: 2009 VS 2019 VS 2025

IV. COMPETITION

  • ADVANSOR A/S
  • BITZER KUHLMASCHINENBAU GMBH
  • BALTIMORE AIRCOIL COMPANY
  • CARNOT REFRIGERATION
  • CARRIER COMMERCIAL REFRIGERATION EUROPE
  • CLARIANT AG
  • DANFOSS GMBH
  • DOWDUPONT
  • EMERSON CLIMATE TECHNOLOGIES
  • GREEN & COOL
  • HALLIBURTON
  • HENRY TECHNOLOGIES
  • KEMIRA OYJ
  • LMP SYSTEMS INC.
  • MAYEKAWA MFG.
  • NALCO AN ECLOAB COMPANY
  • PARKER HANNIFIN CORPORATION
  • SCM FRIGO S.P.A
  • SCHLUMBERGER
  • SHECCO SPRL
  • STEPAN COMPANY
  • THE LUBRIZOL CORPORATION

V. CURATED RESEARCH

Back to Top